Expansion of the OraQuick® HIV Self-Test to individuals aged 14 and older increases access to vital HIV testing for adolescents, addressing a significant public health need. The approval aligns with ...
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (OSUR), please note that the first sentence of the ...
BETHLEHEM, Pa., Nov. 30, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in the fight against HIV, today announced its plans for World AIDS Day. Commemorated ...
Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...
OraSure Technologies Inc. (Bethlehem, PA) has taken another step toward seeking FDA approval for home use of its OraQuick Advance rapid HIV test. In March, the company announced that it had contracted ...
The Chronic Liver Disease Foundation (CLDF) announced today that it's collaborating with Walgreens to offer free hepatitis C (HCV) testing with the OraQuick® HCV Rapid Test at more than 60 Walgreens ...
Co announces the execution of an agreement for the supply of its OraQuick Rapid HIV-1/2 Antibody Test to the Supply Chain Management System. Created with funds from the President's Emergency Plan for ...
Competitor sues OraSure of Bethlehem in federal court over OraQuick product. BETHLEHEM – The crowning achievement of OraSure Technologies is under attack by a rival rapid HIV test company. Inverness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback